Prevalence of CTR1 and ERCC1 Polymorphisms and Response of Biliary Tract Cancer to Gemcitabine-Platinum Chemotherapy

PURPOSE: Biliary tract cancer (BTC)is an aggressive disease with a poor prognosis. Most patients are diagnosed at an advanced stage for which curative surgery is not possible and gemcitabine-platinum chemotherapy is the treatment of choice for advanced cases. Several studies had focused on biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Pongmaneratanakul, Skolchart, Tanasanvimon, Suebpong, Pengsuparp, Thitima, Areepium, Nutthada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464510/
https://www.ncbi.nlm.nih.gov/pubmed/28443323
http://dx.doi.org/10.22034/APJCP.2017.18.3.857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464510/
https://www.ncbi.nlm.nih.gov/pubmed/28443323
http://dx.doi.org/10.22034/APJCP.2017.18.3.857

Ejemplares similares